United Capital Financial Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $539K | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $429K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $231K | Sell |
|
|||||
|
2023
Q4 | $213K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $281K | Hold |
|
|||||
|
2021
Q4 | $373K | Buy |
|
|||||
|
2021
Q3 | $382K | Buy |
|
|||||
|
2021
Q2 | $338K | Buy |
|
|||||
|
2021
Q1 | $225K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $893K | Sell |
|
|||||
|
2019
Q1 | $1.01M | Sell |
|
|||||
|
2018
Q4 | $883K | Sell |
|
|||||
|
2018
Q3 | $1.33M | Buy |
|
|||||
|
2018
Q2 | $1.11M | Sell |
|
|||||
|
2018
Q1 | $1.08M | Buy |
|
|||||
|
2017
Q4 | $1.03M | Sell |
|
|||||
|
2017
Q3 | $1.07M | Buy |
|